A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Agitation Associated With Alzheimer's Dementia
Clinical trial NCT06651567 · RECRUITING
Trial details
- NCT number
- NCT06651567
- Sponsor
- Intra-Cellular Therapies, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-22
- Primary completion
- 2027-12-28
- Enrollment
- 320
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.